BACKGROUND: Folate plays a critical role in DNA methylation, synthesis, and repair. Several epidemiologic studies suggest that higher folate intake is associated with decreased pancreatic cancer risk. OBJECTIVE: We investigated the association between dietary folate intake and pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. DESIGN: Dietary data were collected with the use of a self-administered food-frequency questionnaire (1998-2005). Among the 51,988 male and 57,187 female participants, aged 55-74 y at enrollment, with complete dietary and multivitamin information, 162 men and 104 women developed pancreatic cancer during follow-up (January 1998 to December 2006; median: 6.5 y). We used Cox proportional hazards regression with age as the time metric to calculate hazard ratios (HRs) and 95% CIs. RESULTS: The highest compared with the lowest quartile of food folate was associated with a significantly decreased pancreatic cancer risk among women (> or = 253.3 compared with < or = 179.1 microg/d; HR = 0.47; 95% CI: 0.23, 0.94; P for trend: 0.09) but not among men (> or = 229.6 compared with < or = 158.0 microg/d; HR = 1.20; 95% CI: 0.70, 2.04; P for trend: 0.67; P for interaction by sex: 0.03). There was also a significant inverse trend in risk of pancreatic cancer across increasing quartiles of total folate in women (P for trend: 0.04) but not in men (P for trend: 0.65). Folic acid supplements were not associated with pancreatic cancer. CONCLUSION: These findings support an association between higher food and total folate intakes and decreased risk of pancreatic cancer in women but not in men.
RCT Entities:
BACKGROUND:Folate plays a critical role in DNA methylation, synthesis, and repair. Several epidemiologic studies suggest that higher folate intake is associated with decreased pancreatic cancer risk. OBJECTIVE: We investigated the association between dietary folate intake and pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. DESIGN: Dietary data were collected with the use of a self-administered food-frequency questionnaire (1998-2005). Among the 51,988 male and 57,187 female participants, aged 55-74 y at enrollment, with complete dietary and multivitamin information, 162 men and 104 women developed pancreatic cancer during follow-up (January 1998 to December 2006; median: 6.5 y). We used Cox proportional hazards regression with age as the time metric to calculate hazard ratios (HRs) and 95% CIs. RESULTS: The highest compared with the lowest quartile of food folate was associated with a significantly decreased pancreatic cancer risk among women (> or = 253.3 compared with < or = 179.1 microg/d; HR = 0.47; 95% CI: 0.23, 0.94; P for trend: 0.09) but not among men (> or = 229.6 compared with < or = 158.0 microg/d; HR = 1.20; 95% CI: 0.70, 2.04; P for trend: 0.67; P for interaction by sex: 0.03). There was also a significant inverse trend in risk of pancreatic cancer across increasing quartiles of total folate in women (P for trend: 0.04) but not in men (P for trend: 0.65). Folic acid supplements were not associated with pancreatic cancer. CONCLUSION: These findings support an association between higher food and total folate intakes and decreased risk of pancreatic cancer in women but not in men.
Authors: A F Subar; F E Thompson; A F Smith; J B Jobe; R G Ziegler; N Potischman; A Schatzkin; A Hartman; C Swanson; L Kruse Journal: J Am Diet Assoc Date: 1995-07
Authors: R Z Stolzenberg-Solomon; D Albanes; F J Nieto; T J Hartman; J A Tangrea; M Rautalahti; J Sehlub; J Virtamo; P R Taylor Journal: J Natl Cancer Inst Date: 1999-03-17 Impact factor: 13.506
Authors: P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan Journal: Control Clin Trials Date: 2000-12
Authors: R Z Stolzenberg-Solomon; P Pietinen; M J Barrett; P R Taylor; J Virtamo; D Albanes Journal: Am J Epidemiol Date: 2001-04-01 Impact factor: 4.897
Authors: Halcyon G Skinner; Dominique S Michaud; Edward L Giovannucci; Eric B Rimm; Meir J Stampfer; Walter C Willett; Graham A Colditz; Charles S Fuchs Journal: Am J Epidemiol Date: 2004-08-01 Impact factor: 4.897
Authors: András P Keszei; Bas A J Verhage; Mirjam M Heinen; Royle A Goldbohm; Piet A van den Brandt Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254
Authors: Regan L Bailey; James L Mills; Elizabeth A Yetley; Jaime J Gahche; Christine M Pfeiffer; Johanna T Dwyer; Kevin W Dodd; Christopher T Sempos; Joseph M Betz; Mary Frances Picciano Journal: Am J Clin Nutr Date: 2010-06-23 Impact factor: 7.045
Authors: Ying Bao; Dominique S Michaud; Donna Spiegelman; Demetrius Albanes; Kristin E Anderson; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Niclas Håkansson; Pamela L Horn-Ross; Eric J Jacobs; Cari M Kitahara; James R Marshall; Anthony B Miller; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Jarmo Virtamo; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner Journal: J Natl Cancer Inst Date: 2011-10-27 Impact factor: 13.506
Authors: Wen-Yi Huang; L Joseph Su; Richard B Hayes; Lee E Moore; Hormuzd A Katki; Sonja I Berndt; Joel L Weissfeld; Srinivasan Yegnasubramanian; Mark P Purdue Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-09-20 Impact factor: 4.254